Join CueLog in

Measure everything. Guess nothing.

Get started

Every protocol backed by evidence. Every intervention tracked to outcome.

Proactive, not reactive

Traditional medicine waits for disease to appear, then treats symptoms. Cue inverts the model: capture deep biological data, identify trajectory deviations before they become pathology, and intervene with precision while the window for meaningful change is wide open.
Data over intuitionData > Decision
Data over intuition

Every clinical decision begins with objective measurement. Comprehensive bloodwork, DEXA analysis, validated instruments, and wearable data create a 360° picture before any intervention is considered.

Optimization, not just preventionOptimal, not "normal"
Optimization, not just prevention

We don't aim for "normal ranges." Normal is a statistical average of an often unhealthy population. Cue targets optimal — the biomarker levels associated with peak performance and longevity.

Stack, don't sequenceAll levers, day one
Stack, don't sequence

Most clinics try one intervention at a time and wait months. Cue deploys coordinated multi-modal protocols — lifestyle, supplementation, and medical intervention simultaneously — for dramatic 12-week results.

The Health OS loop

Cue's core clinical engine is a continuous feedback loop. Not a one-off health check — a living system that learns from every data point and refines your protocol in real time.
1

Measure

Comprehensive baseline capture: 60+ blood biomarkers, full-body DEXA composition analysis, validated clinical questionnaires, and wearable physiological data. No stone unturned.

2

Interpret

Physician-led analysis converts raw data into clinical insight. Every biomarker is scored against optimal performance ranges — not lab "normal" ranges derived from a general, often unhealthy population.

3

Intervene

Coordinated multi-modal protocols deployed simultaneously — lifestyle optimization, targeted supplementation, and medical intervention. All three tiers from day one.

4

Track

Continuous monitoring via wearables, app-based symptom logging, and scheduled retesting. Progress is visible in real time — not just at your next appointment.

5

Learn

Each data cycle refines the model. Protocols are adjusted based on measured response, creating an increasingly precise health strategy that evolves with your biology.

What we measure

Unlike clinics that run a basic panel and call it comprehensive, Cue captures data across every system that governs male health, performance, and longevity.
01

Endocrine Panel

Full hormonal axis — testosterone, oestrogen, thyroid, adrenal, and growth hormone pathways.

14
02

Metabolic & Inflammation

Insulin sensitivity, glucose regulation, and systemic inflammatory burden.

4
03

Advanced Heart Health

Advanced lipid profiling including ApoB, Lp(a), and atherogenic ratios.

9
04

DEXA Scan Analysis

Regional body composition, visceral fat, bone density, and lean mass indexing.

7
05

Complete Blood Count

Full haematology with white cell differential and red cell morphology.

15
06

Organ Function & Micronutrients

Liver, kidney, pancreatic enzymes, filtration rate, and essential cofactors.

16
07

Prostate Screening

Total and free PSA with ratio — baseline and longitudinal surveillance.

3
08

Longevity & Performance

VO₂max, grip strength, and cardiovascular vitals — the strongest predictors of all-cause mortality.

3
09

Clinical Instruments

Validated questionnaires for androgen deficiency, mood, sleep, and urological function.

7
10

Wearable Integration

Continuous HRV, sleep architecture, activity, and recovery tracking.

5

Unique score intelligence

Every biomarker is scored against optimal performance ranges — not lab "normal" ranges derived from a general, often unhealthy population. You see exactly where you stand, what needs attention, and what's already strong.

Three tiers. Deployed

Most clinics exhaust lifestyle advice before considering supplementation, and only escalate to medical intervention as a last resort. Cue stacks all three tiers from day one — because your biology does not wait for sequential experiments.
Foundation - Lifestyle Architecture
Foundation
Lifestyle Architecture

Structured protocols for the levers you control daily. Not generic advice - specific, measurable targets calibrated to your data.

Targeted - Evidence-Based Supplementation
Targeted
Evidence-Based Supplementation

Every supplement prescribed with a mechanistic rationale tied to your specific biomarker profile. No kitchen-sink stacks - only what moves the needle.

Medical - Pharmaceutical Precision
Medical
Pharmaceutical Precision

When lifestyle and supplementation aren't sufficient, medical intervention is initiated under direct physician oversight — with strict clinical indications.

Built on science, not trends

Every protocol at Cue is grounded in peer-reviewed research. We prioritize interventions with strong effect sizes, reproducible results, and clear clinical relevance.

Androgen decline accelerates metabolic dysfunction

Testosterone & Male Aging

Cross-sectional and longitudinal data consistently show that declining testosterone is associated with increased visceral adiposity, insulin resistance, cardiovascular risk, and all-cause mortality — independent of age.

Travison et al., JCEM 2007·Wu et al., NEJM 2010·Corona et al., Eur J Endocrinol 2020
DEXA-guided interventions outperform weight-based targets

DEXA-guided interventions outperform weight-based targets

Body Composition

Body weight alone is a poor metric. DEXA-derived lean mass index (ALMI) and visceral adipose tissue volume are independent predictors of metabolic health, functional capacity, and mortality risk.

Prado et al., Clin Nutr 2018·Batsis et al., JAGS 2017·Shepherd et al., J Clin Densitom 2017

Insulin resistance precedes disease by a decade

Metabolic Health

HOMA-IR elevation and hyperinsulinemia are detectable years before HbA1c rises. Fasting insulin is one of the most powerful early markers of metabolic trajectory — yet rarely tested in conventional practice.

Kraft et al., J Ins Resistance 2017·Reaven, Diabetes 1988·Crofts et al., Diabetology 2015
ApoB outperforms LDL-C as a risk predictor

ApoB outperforms LDL-C as a risk predictor

Cardiovascular Risk

Apolipoprotein B captures atherogenic particle count directly — a more accurate predictor of cardiovascular events than LDL cholesterol alone. Combined with Lp(a) testing, it enables truly personalized risk stratification.

Sniderman et al., Lancet 2019·Mora et al., JACC 2020·Nordestgaard et al., EHJ 2010

Personalized hormone optimization

Cue

  • Root-cause hormone mapping
  • Personalized bioidentical therapy
  • Advanced biomarker diagnostics
  • Data-driven clinical personalization
  • Long-term optimization
  • Continuous monitoring

Traditional clinic

  • Symptom-based prescriptions
  • Generic testosterone dosing
  • Minimal or outdated labs
  • One-size-fits-all plans
  • Short-term cycles
  • No ongoing monitoring

Physician-led. Always.

Cue is not a wellness brand with a medical advisor. It's a physician-founded clinical platform where every protocol, every prescription, and every patient interaction is under direct medical oversight.
Anders Kassem, M.D.
Chief Medical Officer

Anders Kassem, M.D.

Physician-founder leading Cue's medical direction across product, operations, and care delivery, with responsibility for clinical quality, safety, and outcomes.

CMO Professional affiliations

Ready to see your data?

Book your baseline assessment. 60+ biomarkers, full DEXA analysis, and a clinical roadmap — in a single visit.

Start testing